Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps
Novavax(US:NVAX) Reutersยท2025-10-14 10:09Shah Capital has urged Novavax's board to pursue a sale of the biotech, citing a third consecutive year of poor roll-out of its COVID-19 shot, the hedge fund said on Tuesday. ...